# Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA).

> **NCT04605107** · PHASE4 · COMPLETED · sponsor: **Genuine Research Center, Egypt** · enrollment: 60 (actual)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** Epifasi: Human chorionic gonadotrophin
- **DRUG:** Pregnyl: Human chorionic gonadotrophin

## Key facts

- **NCT ID:** NCT04605107
- **Lead sponsor:** Genuine Research Center, Egypt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-30
- **Primary completion:** 2015-01-08
- **Final completion:** 2015-03-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04605107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04605107, "Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA).". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04605107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*